To evaluate if dihydroceramides could cause insulin resistance in vitro, we performed an insulin-stimulated glycogen synthesis assay in human primary myotubes treated with a mixture of dihydroceramides at a similar concentration observed in the serum of individuals with obesity, with and without T2D. The gene discussed is INS; the disease is obesity disorder.